Skip to content
Market Tracked raises in 2026$3.41B+$183M this week Rounds77 LatestBlue J$176M Series E Wednesday, November 11

Parambil

Parambil is AI medical record review software for mass tort and complex litigation.

relke

Relke develops relCase, a Chilean legal SaaS platform for lawyers and law firms to track court matters, alerts, documents, hearings, tasks, and receivables.

Parambil vs relke

At a Glance

DetailParambilrelke
CategoryeDiscoveryeDiscovery
Total raised$8MNot disclosed
Rounds tracked2Not disclosed
Latest roundSeed, $6M · Jan 2026Not disclosed
Last valuationNot disclosedNot disclosed
Lead investorsBling Capital, Daybreak VenturesNot disclosed
Built forMid-size firms, BoutiquesNot disclosed
HeadquartersUnited StatesNot disclosed

Funding, Side by Side

Parambil$8M
relkeUndisclosed
Parambil rounds
  1. Jan 2026Seed$6M
  2. Jan 2025Pre-Seed$2M
relke rounds

No public rounds tracked yet.

Our Take

We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.

Quick Answers

Which has raised more, Parambil or relke?
Parambil has raised $8M in disclosed funding, compared with no disclosed amount for relke.
What is Parambil best for?
Parambil is AI medical record review software for mass tort and complex litigation.
What is relke best for?
Relke develops relCase, a Chilean legal SaaS platform for lawyers and law firms to track court matters, alerts, documents, hearings, tasks, and receivables.

Source: Legal Tech Circle funding data, from public announcements. Updated November 11, 2026.